Sentences with phrase «recent clinical studies»

Recent clinical studies in humans show that probiotcs can help regulate the digestive system.

The unsaturated fats of fish have been the subject of many recent clinical studies.

Recent clinical studies have documented the suppressive effect of selenium treatment on serum anti-thyroid peroxidase concentrations in patients with HT.

Recent clinical studies have also shown great benefits in weight loss, too.

The research is somewhat divided about how much red raspberry leaf consumption during pregnancy can benefit a woman in labor, but recent clinical studies have concluded that:

Recent clinical studies support the development of DG041 as an effective anti-platelet that does not increase bleeding risk deCODE genetics (Nasdaq: DCGN) today announced progress in the development of DG041, the company's Phase II developmental compound for the...

To block this signal, recent clinical studies have focused on inhibiting the activation of the B - cell receptor as a treatment for non-Hodgkin lymphoma patients, but with variable success.

However, those guidelines from 2011 predate more recent clinical studies of HPV testing that were analyzed in today's paper.

In support of this notion, recent clinical studies have demonstrated that the breast - fed infant has a lower risk of acquiring urinary tract infections.

Recent clinical studies prove that the MAM Perfect Pacifier supports healthy teeth and jaw development, and in a recent study, the MAM Perfect Pacifier was shown to be the tooth friendliest of any pacifiers tested.

A recent clinical study by Dr. Antonarakis and colleagues showed that mCRPC in men who had AR - V7 in circulating tumor cells was resistant to the hormone drugs enzalutamide and abiraterone.

A recent clinical study that emerged from their research revealed epileptic activity in roughly 40 % of Alzheimer patients tested.

However, a recent clinical study showed that lowering plasma ApoC - III levels with volanesorsen, a generation 2.0 + ApoC - III — specific antisense oligonucleotide (ASO), dramatically lowered elevated plasma TG levels in patients who have genetic defects in LPL (familial chylomicronemia syndrome [FCS]-RRB-(16).

In a recent clinical study, BetaTOR decreased protein breakdown in muscle by 57 % (Wilkinson et al., 2013).

Recent clinical study found this carotenoid to be the strongest antioxidant against singlet oxygen (a reactive oxygen species that directly damages biological lipids, proteins and DNA).

Not exact matches

In recent years, Levine and others have used clinical studies to prove that even in healthy people, a chair - based lifestyle sets up the physiological conditions for the onset of Type 2 diabetes, cardiovascular disease, obesity — and ultimately, shorter lifespans.

A recent study looked at how 244 compounds in 413 clinical trials fared for Alzheimer's disease between 2002 and 2012.

One recent study in the «Journal of Clinical Epidemiology» showed that women who nursed babies for at least 25 months total of their own life had a decreased risk compared to mothers who did not nurse.

A recent study published in the Journal of Allergy and Clinical Immunology found that the percentage of children with peanut allergies has doubled in the last five years.

A recent study in the American Journal of Clinical Nutrition lends support to this line of thinking, whereby researchers observed that excessive amounts of nutrition early in life are associated with being overweight later in life.

A recent UK study [8] covering a limited selection of these costs suggested that by age 28, costs for individuals with a clinical diagnosis of conduct disorder were 10.0 times higher than for those with no problems (CI: 3.6 to 20.9) and costs for those with conduct problems not meeting diagnostic criteria were 3.5 times higher (CI: 1.7 to 6.2).

According to the recent study, which will be published next month in the print version of the American Journal of Clinical Nutrition, breastfeeding can cut the risk of breast cancer by up to 91 percent.

The initiative was introduced to the United Kingdom in 1993, but, although improvements have been reported, 3 rates of breast feeding in the UK are still among the lowest in the world.4 5 Recent reports from the National Institute for Health and Clinical Excellence (NICE) urge NHS units to become baby friendly to improve rates of breast feeding and save money.4 6 Data from the millennium cohort study, however, show that though participating maternity units in the UK increased rates of initiation of breastfeeding, duration did not increase.5 Other strategies are therefore required to support mothers in the UK to breast feed for the recommended time.

On Sunday, June 16, researchers released a recent study conducted by the Association for Professionals in Infection Control and Epidemiology (APIC) that was conducted to see how long the bacteria methicillin - resistant Staphylococcus aureus (MRSA) could survive on fabrics used in hospital, clinical and long term care homes.

In addition, there was no effect on breastfeeding duration when the pacifier was introduced at 1 month of age.280 A more recent systematic review found that the highest level of evidence (ie, from clinical trials) does not support an adverse relationship between pacifier use and breastfeeding duration or exclusivity.281 The association between shortened duration of breastfeeding and pacifier use in observational studies likely reflects a number of complex factors such as breastfeeding difficulties or intent to wean.281 A large multicenter, randomized controlled trial of 1021 mothers who were highly motivated to breastfeed were assigned to 2 groups: mothers advised to offer a pacifier after 15 days and mothers advised not to offer a pacifier.

The findings of the experimental study, presented in the most recent issue of the American Journal of Clinical Nutrition, suggest that improving maternal DHA nutrition has a favorable programming effect on the fetus that influences body composition in early childhood.

The study by Alison McLeish, a University of Cincinnati associate professor of psychology, Christina Luberto, a recent doctoral graduate from UC and clinical fellow at Massachusetts General Hospital, and Emily O'Bryan, a graduate student in the UC Department of Psychology, will be presented at the Association for Behavioral and Cognitive Therapies (ABCT) 49th Annual Convention.

Those studies, including their recent paper published in the medical journal Expert Review of Clinical Pharmacology, which demonstrated that the benefits of taking statins have been exaggerated and are misleading.

In a recent study, published in the Journal of Clinical Psychiatry, PTSD patients allowed to choose between therapies ended up costing about $ 1,622 less on average per patient per year compared with patients who were assigned treatment.

In their recent study, the researchers took a retrospective look at 697 patients who'd received transplants at Seattle Cancer Care Alliance, Fred Hutch's clinical care partner, between 1993 and 2015 and who had also tested positive for rhinovirus.

To understand how this pathway is implemented, in a recent study published in JAMA, researchers at Brigham and Women's Hospital and the London School of Economics and Political Science (LSE) examined the pre-approval and post-approval clinical trials of drugs granted FDA Accelerated Approval between 2009 and 2013.

Further helping to identify the connection between anti-tTG levels and celiac disease, a study in Clinical Gastroenterology and Hepatology reconfirms the recent European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) guidelines, which recognize that the likelihood for celiac disease increases with increasing antibody concentration.

But the implications of a recent study demonstrating this relationship are anything but simple and could influence both the design of future clinical trials and the goals of oncologists treating cancer.

Another recent study, published last week in the Journal of Clinical Sleep Medicine, found that as many as 94 percent of adults with Down's syndrome had some sort of obstructive sleep apnea — and in 69 percent of those patients it was severe.

«While the present report suggests that optimal outcome measures for FXS are not yet fully developed, the recent failures of clinical trials in the FXS treatment field represent an opportunity to implement novel study designs and methodologies,» concludes Budimirovic.

Miller says the response in this study, published in the Journal of Clinical Lipidology, may confirm other research findings about polyunsaturated fats: «Recent data suggest that PUFA (but not MUFA) activates signaling in the brain to reduce appetite, so this may be one reason for the bigger weight drop between the groups.»

Results from recent clinical trials and studies in animals suggest that a class of anti-cancer drugs called angiogenesis inhibitors may be able to temporarily reduce interstitial pressure and improve the efficacy of chemotherapy and radiation treatments.

A recent study suggests that self - reported memory complaints might predict clinical memory impairment later in life.

This research is part of the Pulmonary Nodule Plasma Proteomic Classifier (PANOPTIC) study, a clinical trial of 685 patients 40 years old or older, with newly discovered lung nodules 8 to 30 millimeters in diameter as shown on a recent (fewer than 60 days old) CT scan.

The recent study, published in the journal Archives of Clinical Neuropsychology, focuses on using a simple test of visual flicker to evaluate an individual's level of executive cognitive abilities, such as shifting attention between different tasks, planning or organizing and problem solving.

A recent study, also published in the Journal of Clinical Oncology, found that gene panel testing for CRC was cost - effective.

These macrophage - derived mediators may have potential as biomarkers to reflect the urinary stone risk, according to a new study from Japan, which was recently presented at the recent 2nd Meeting of the EAU Section of Urolithiasis and received Clinical Research Award.

In recent years, a number of clinical studies have suggested that «matching» particular types of alcoholics with particular treatments — for example, teaching someone with poor impulse control how to think through actions before taking them — would help them quit drinking.

However, a recent published review of basic science journals, including studies of cells in culture from high impact cardiovascular journals, and of basic and clinical scientific literature, suggests that sex of experimental material is not consistently reported.

In recent years, researchers have developed so - called «senolytic» drugs that wipe out senescent cells in aging mice and mouse models of age - related disease, exploiting the high dependence of these cells on specific biochemical survival pathways.9, 10 In these studies, senolytic drugs have restored exercise capacity9 and formation of new blood and immune precursor cells11 in aging mice to near youthful norms, and prevented or treated mouse models of diseases of aging like osteoarthritis, 12 fibrotic lung disease, 13 hair loss, 14 atherosclerosis, 15,16 and age - related diseases of the heart itself.9 UNITY Biotechnology is leading a growing charge toward the clinic, with human clinical trials expected to begin in 2019.

Recent approval from the U.S. Food and Drug Administration to begin clinical studies was based on compelling activity upon IACS - 10759 treatment in multiple preclinical models of AML.

In one eye - opening review of recent research, Charles Drake, M.D., Ph.D., of Johns Hopkins, who is also a member of CRI's clinical trials network, discussed several cancer vaccines that are making progress, including coxsackievirus A21, an oncolytic virus vaccine being studied in late stage melanoma, and NewLink's algenpantucel - L in pancreatic cancer (HyperAcute ® pancreas).

A recent grant from the National Institutes of Health's National Heart, Lung and Blood Institute is allowing Felder and his colleagues to continue their studies, and they are now seeking volunteers for their ongoing salt consumption clinical trials.

Fueled by a recent resurgence in public financing and compelling clinical data for indications as diverse as acute macular degeneration and pancreatic cancer, a growing number of cell therapies are driving toward pivotal clinical studies and commercialization.

Recent clinical trials, such as the HVTN 505 study that was stopped because the vaccine was shown to be ineffective at preventing HIV, have generated new challenges to the field.